Search Results - "Velard, F"

Cutibacterium acnes : the Urgent Need To Identify Diagnosis Markers by Mongaret, C, Velard, F, Reffuveille, F

“…role is well described during acne but remains a mystery regarding its implication in bone and prosthesis or cerebrospinal fluid shunt infections. The main…”
Get full text

Effect of strontium-substituted biphasic calcium phosphate on inflammatory mediators production by human monocytes by Buache, E., Velard, F., Bauden, E., Guillaume, C., Jallot, E., Nedelec, J.M., Laurent-Maquin, D., Laquerriere, P.

“…In contact or when engulfed by monocytes wear debris (▪) induce a production of several mediators including pro-inflammatory (TNF-α, IL-1β, IL-6 and IL-18),…”
Get full text

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies by Jacquot, J., Delion, M., Gangloff, S., Braux, J., Velard, F.

“…Mutations within the gene encoding for the chloride ion channel cystic fibrosis transmembrane conductance regulator (CFTR) results in cystic fibrosis (CF), the…”
Get full text

Haemostatic sponges as an alternative to granular bone substitute for sinus lifts by Okley, S., Mauprivez, C., Prada, P., Dubus, M., Velard, F., Rahouadj, R., Kerdjoudj, H., Baldit, A.

“…Insufficient residual alveolar bone height is a common obstacle for the placement of dental implants in the posterior maxilla. Sinus lifting procedure involves…”
Get full text

Identification of macro-heterogenous mechanical behaviour of temporomandibular joint disc by Tappert, L. K., Baldit, A., Guillaume, C, Velard, F, Lipinski, P.

“…The temporomandibular joint (TMJ) is one of the most utilized joints of the human body, not even resting during sleep (for instance people suffering of…”
Get full text

In vitro dissolution and corrosion study of calcium phosphate coatings elaborated by pulsed electrodeposition current on Ti6Al4V substrate by Drevet, R., Velard, F., Potiron, S., Laurent-Maquin, D., Benhayoune, H.

“…Calcium-deficient hydroxyapatite (Ca-def-HAP) coatings on titanium alloy (Ti6Al4V) substrates are elaborated by pulsed electrodeposition. In vitro…”
Get full text

Harnessing Wharton’s jelly stem cell differentiation into bone-like nodule on calcium phosphate substrate without osteoinductive factors by Mechiche Alami, S., Rammal, H., Boulagnon-Rombi, C., Velard, F., Lazar, F., Drevet, R., Laurent Maquin, D., Gangloff, S.C., Hemmerlé, J., Voegel, J.C., Francius, G., Schaaf, P., Boulmedais, F., Kerdjoudj, H.

“…Bone regenerative medicine. [Display omitted] An important aim of bone regenerative medicine is to design biomaterials with controlled chemical and…”
Get full text

Induction of sulfadiazine resistance in vitro in Toxoplasma gondii by Doliwa, C., Escotte-Binet, S., Aubert, D., Velard, F., Schmid, A., Geers, R., Villena, I.

“…[Display omitted] ► Adaptation of a specific Toxoplasma enzyme immunoassay on Vero cells. ► Determination of IC50 values on several T. gondii strains. ►…”
Get full text

The acute inflammatory response to copper(II)-doped biphasic calcium phosphates by Thoraval, L., Thiébault, E., Siboni, R., Moniot, A., Guillaume, C., Jacobs, A., Nedelec, J.-M., Renaudin, G., Descamps, S., Valfort, O., Gangloff, S.C., Braux, J., Marchat, D., Velard, F.

“…Infection and inflammation are two key features to consider to avoid septic or aseptic loosening of bone-implanted biomaterials. In this context, various…”
Get full text

Intracellular calcium oscillations in articular chondrocytes induced by basic calcium phosphate crystals lead to cartilage degradation by Nguyen, C, Lieberherr, M, Bordat, C, Velard, F, Côme, D, Lioté, F, Ea, H.-K

“…Summary Objective Basic calcium phosphate (BCP) crystals, including octacalcium phosphate (OCP), carbonated-apatite (CA) and hydroxyapatite (HA) crystals are…”
Get full text

39 Is sphingosine 1-phosphate pathway involved in bone disease development in cystic fibrosis? by Jourdain, M.-L, Abdallah, D.M, Guillaume, C, Le Pimpec-Barthes, F, Gangloff, S.C, Sermet-Gaudelus, I, Jacquot, J, Velard, F

Get full text

21 Cystic fibrosis bone disease: an increased RANK-L-to-OPG ratio in human osteoblasts with the F508del mutation in CFTR by Delion, M, Velard, F, Guillaume, C, Gangloff, S.C, Pimpec-Barthes, F. Le, Sermet-Gaudelus, I, Jacquot, J

Get full text

Chitosan/hydroxyapatite hybrid scaffold for bone tissue engineering by Brun, V, Guillaume, C, Mechiche Alami, S, Josse, J, Jing, J, Draux, F, Bouthors, S, Laurent-Maquin, D, Gangloff, S C, Kerdjoudj, H, Velard, F

“…To favor regeneration following critical bone defect, a combination of autologous bone graft and biomaterials is currently used. Major drawbacks of such…”
Get more information

WS06.5 New insights into the pathogenesis and potential therapies of cystic fibrosis (CF) bone disease by Velard, F, Delion, M, Tabary, O, Guillaume, C, Sermet-Gaudelus, I, Pimpec-Barthes, F. Le, Ingersoll, S, Gangloff, S.C, Tirouvanziam, R, Jacquot, J

Get full text

Biocompatibility of sol-gel hydroxyapatite-titania composite and bilayer coatings by Sidane, D., Rammal, H., Beljebbar, A., Gangloff, S.C., Chicot, D., Velard, F., Khireddine, H., Montagne, A., Kerdjoudj, H.

“…Titania-Hydroxyapatite (TiO2/HAP) reinforced coatings are proposed to enhance the bioactivity and corrosion resistance of 316L stainless steel (316L SS)…”
Get full text

ePS05.5 Cystic fibrosis bone disease: Is the CFTR corrector C18 an option for therapy? by Velard, F, Delion, M, Lemaire, F, Tabary, O, Touqui, L, Le Pimpec-Barthes, F, Sermet-Gaudelus, I, Gangloff, S, Jacquot, J

“…Low bone mass is commonly seen in patients with cystic fibrosis (CF). We investigated whether the F508del mutation could affect the expression of osteoblast…”
Get full text

65 Miglustat therapy ameliorates bone mass and bone formation in F508del cystic fibrosis mice by Le Henaff, C, Häy, E, Velard, F, Marty, C, Marie, P, Jacquot, J

Get full text

Gene screening of Wharton's jelly derived stem cells by Mechiche Alami, S, Velard, F, Draux, F, Siu Paredes, F, Josse, J, Lemaire, F, Gangloff, S C, Graesslin, O, Laurent-Maquin, D, Kerdjoudj, H

“…Stem cells are the most powerful candidate for the treatment of various diseases. Suitable stem cell source should be harvested with minimal invasive…”
Get more information

WS6.7 Cystic fibrosis and bone disease: defective osteoblast maturation with the F508del mutation in CFTR by Velard, F, Delion, M, Le Henaff, C, Tabary, O, Guillaume, C, Barthes, F, Touqui, L, Gangloff, S, Sermet-Gaudelus, I, Jacquot, J

Get full text

CFTR and defective human osteoblasts: new insights in the osteoporotic phenotype of cystic fibrosis by Le Heron, L, Velard, F, Touqui, L, Moriceau, S, Sermet-Gaudelus, I, Laurent-Maquin, D, Jacquot, J

Get full text